Extending our understanding of how antimalarial artemisinin drugs affect inhibitory neurotransmission

Artemisinins are pharmaceutical compounds used against the pathogen that causes malaria. However, these substances also have multiple targets in humans which may either be pharmacologically exploited or result in undesirable side effects. Recently, scientists from Würzburg have been able to elucidate one of the underlying molecular mechanisms by showing how these drugs inhibit the vitamin B6 generating enzyme in humans. The results were published in the scientific journal PNAS.

Quelle: IDW Informationsdienst Wissenschaft